ES2038650T3 - Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus. - Google Patents
Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.Info
- Publication number
- ES2038650T3 ES2038650T3 ES198787118407T ES87118407T ES2038650T3 ES 2038650 T3 ES2038650 T3 ES 2038650T3 ES 198787118407 T ES198787118407 T ES 198787118407T ES 87118407 T ES87118407 T ES 87118407T ES 2038650 T3 ES2038650 T3 ES 2038650T3
- Authority
- ES
- Spain
- Prior art keywords
- retrovirus
- dideshidrotimidina
- deoxytimidin
- desoxi
- eno
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
ESTA INVENCION DESCRIBE EL USO DE LA 3''-DESOXITIMIDINA-2''-ENE (3''-DESOXI-2'',3''-DIDESHIDROTIMIDINA) EN EL TRATAMIENTO DE PACIENTES INFECTADOS CON UN RETROVIRUS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/942,666 US4978655A (en) | 1986-12-17 | 1986-12-17 | Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2038650T3 true ES2038650T3 (es) | 1993-08-01 |
Family
ID=25478432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198787118407T Expired - Lifetime ES2038650T3 (es) | 1986-12-17 | 1987-12-11 | Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus. |
Country Status (22)
Country | Link |
---|---|
US (1) | US4978655A (es) |
EP (1) | EP0273277B1 (es) |
JP (1) | JPH07116041B2 (es) |
KR (1) | KR960000433B1 (es) |
AT (1) | ATE77554T1 (es) |
AU (1) | AU593405B2 (es) |
CA (1) | CA1293447C (es) |
DE (1) | DE3780016T2 (es) |
DK (1) | DK174627B1 (es) |
EG (1) | EG19157A (es) |
ES (1) | ES2038650T3 (es) |
FI (1) | FI875544A (es) |
GR (1) | GR3005691T3 (es) |
HK (1) | HK55896A (es) |
IE (1) | IE60866B1 (es) |
IL (1) | IL84790A (es) |
LU (1) | LU88822I2 (es) |
NL (1) | NL960024I2 (es) |
NZ (1) | NZ222935A (es) |
PH (1) | PH26380A (es) |
PT (1) | PT86346B (es) |
ZA (1) | ZA877171B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5175292A (en) * | 1988-01-20 | 1992-12-29 | Regents Of The University Of Minnesota | Intermediates for the preparation of dideoxycarbocyclic nucleosides |
US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
FI95269C (fi) * | 1989-05-15 | 1996-01-10 | Squibb Bristol Myers Co | 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja |
US6207650B1 (en) | 1989-05-15 | 2001-03-27 | Bristol-Myers Squibb Company | Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine |
US5608048A (en) * | 1995-06-05 | 1997-03-04 | Bristol-Myers Squibb Company | d4 T polymorphic Form 1 process |
US5840711A (en) * | 1995-06-21 | 1998-11-24 | University Of Kentucky Research Foundation | Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome |
CA2189097A1 (en) | 1995-11-15 | 1997-05-16 | Pin-Fang Lin | Composition and method of treating retroviral infection |
US5719132A (en) * | 1996-06-27 | 1998-02-17 | Bristol-Myers Squibb Company | Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil |
WO2000016625A1 (en) * | 1998-09-23 | 2000-03-30 | University Of Kentucky Research Foundation | Antiviral drug compositions containing lithium inorganic salts |
NZ522250A (en) | 2000-03-30 | 2004-09-24 | Bristol Myers Squibb Co | Sustained release beadlets containing stavudine stabilised by magnesium stearate |
EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
BRPI0407374A (pt) | 2003-02-19 | 2006-01-10 | Univ Yale | Análogos de nucleosìdeo antiviral e métodos para tratar infecções virais, especialmente infecções de hiv |
US20040200730A1 (en) * | 2003-04-14 | 2004-10-14 | Kyo Jibiki | Hydrometallurgical copper recovery process |
ATE505196T1 (de) | 2004-07-27 | 2011-04-15 | Gilead Sciences Inc | Nukleosid phosphonat konjugate als anti hiv mittel |
AP2008004389A0 (en) * | 2005-08-31 | 2008-04-30 | Cipla Ltd | Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine |
CN102272134B (zh) | 2008-12-09 | 2013-10-16 | 吉里德科学公司 | Toll样受体调节剂 |
US20110223131A1 (en) | 2010-02-24 | 2011-09-15 | Gilead Sciences, Inc. | Antiviral compounds |
WO2016001907A1 (en) | 2014-07-02 | 2016-01-07 | Prendergast Patrick T | Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents. |
MX2017000026A (es) | 2014-07-11 | 2017-05-01 | Gilead Sciences Inc | Moduladores de receptores tipo toll para el tratamiento de virus de inmunodeficiencia humana (vih). |
US20180263985A1 (en) | 2015-09-15 | 2018-09-20 | Gilead Sciences, Inc. | Modulators of toll-like receptors for the treatment of hiv |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3322747A (en) * | 1965-04-01 | 1967-05-30 | Merck & Co Inc | Thionocarbonate nucleosides |
US3817982A (en) * | 1971-12-29 | 1974-06-18 | Syntex Inc | 2{40 ,3{40 -unsaturated nucleosides and method of making |
GB1523865A (en) * | 1974-09-02 | 1978-09-06 | Wellcome Found | Purine compunds and salts thereof |
JPS5943550B2 (ja) * | 1975-08-29 | 1984-10-23 | 田辺製薬株式会社 | 不飽和ヌクレオシドの製法 |
DE3515870A1 (de) * | 1985-05-03 | 1986-11-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von 5-fluortoluol-2,4-disulfochlorid |
US4710492A (en) * | 1986-06-23 | 1987-12-01 | Yale University | 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses |
NL8700089A (nl) * | 1987-01-15 | 1988-08-01 | Stichting Rega V Z W | Therapeutische toepassing van dideoxythymidine en dideoxythymidineen. |
DE3806633A1 (de) * | 1987-09-01 | 1989-03-09 | Bayer Ag | Antivirales mittel |
JP2648329B2 (ja) * | 1987-09-18 | 1997-08-27 | エフ・ホフマン−ラ ロシュ アーゲー | エイズの予防または治療用医薬組成物 |
SE8704298D0 (sv) * | 1987-11-03 | 1987-11-03 | Astra Ab | Compounds for use in therapy |
JPH0227782A (ja) * | 1988-07-15 | 1990-01-30 | Hikari Gijutsu Kenkyu Kaihatsu Kk | 半導体発光素子 |
JPH0438727A (ja) * | 1990-06-04 | 1992-02-07 | Sharp Corp | 光学式ピックアップ装置の対物レンズ塵埃付着防止機構 |
-
1986
- 1986-12-17 US US06/942,666 patent/US4978655A/en not_active Expired - Lifetime
-
1987
- 1987-09-23 ZA ZA877171A patent/ZA877171B/xx unknown
- 1987-09-29 PH PH35869A patent/PH26380A/en unknown
- 1987-10-07 EG EG57787A patent/EG19157A/xx active
- 1987-10-23 DK DK198705570A patent/DK174627B1/da not_active IP Right Cessation
- 1987-11-06 AU AU80900/87A patent/AU593405B2/en not_active Expired
- 1987-11-24 JP JP62294251A patent/JPH07116041B2/ja not_active Expired - Lifetime
- 1987-11-30 IE IE324587A patent/IE60866B1/en not_active IP Right Cessation
- 1987-12-02 CA CA000553354A patent/CA1293447C/en not_active Expired - Lifetime
- 1987-12-11 EP EP87118407A patent/EP0273277B1/en not_active Expired - Lifetime
- 1987-12-11 PT PT86346A patent/PT86346B/pt unknown
- 1987-12-11 ES ES198787118407T patent/ES2038650T3/es not_active Expired - Lifetime
- 1987-12-11 IL IL84790A patent/IL84790A/xx not_active IP Right Cessation
- 1987-12-11 LU LU88822C patent/LU88822I2/fr unknown
- 1987-12-11 AT AT87118407T patent/ATE77554T1/de active
- 1987-12-11 DE DE8787118407T patent/DE3780016T2/de not_active Expired - Lifetime
- 1987-12-15 NZ NZ222935A patent/NZ222935A/xx unknown
- 1987-12-16 FI FI875544A patent/FI875544A/fi not_active Application Discontinuation
- 1987-12-17 KR KR1019870014383A patent/KR960000433B1/ko not_active IP Right Cessation
-
1992
- 1992-09-14 GR GR920402023T patent/GR3005691T3/el unknown
-
1996
- 1996-03-28 HK HK55896A patent/HK55896A/xx not_active IP Right Cessation
- 1996-10-07 NL NL960024C patent/NL960024I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
NL960024I2 (nl) | 1997-06-02 |
AU593405B2 (en) | 1990-02-08 |
CA1293447C (en) | 1991-12-24 |
FI875544A (fi) | 1988-06-18 |
LU88822I2 (fr) | 1997-01-06 |
DK557087D0 (da) | 1987-10-23 |
DE3780016T2 (de) | 1992-12-24 |
ZA877171B (en) | 1988-03-24 |
DK557087A (da) | 1988-06-18 |
PT86346A (en) | 1988-01-01 |
PT86346B (pt) | 1990-11-07 |
NL960024I1 (nl) | 1996-12-02 |
GR3005691T3 (es) | 1993-06-07 |
PH26380A (en) | 1992-06-01 |
DE3780016D1 (de) | 1992-07-30 |
KR960000433B1 (ko) | 1996-01-06 |
DK174627B1 (da) | 2003-07-28 |
EP0273277A3 (en) | 1989-09-13 |
IL84790A (en) | 1993-03-15 |
IE873245L (en) | 1988-06-17 |
ATE77554T1 (de) | 1992-07-15 |
KR880007079A (ko) | 1988-08-26 |
FI875544A0 (fi) | 1987-12-16 |
JPS63215632A (ja) | 1988-09-08 |
IL84790A0 (en) | 1988-05-31 |
AU8090087A (en) | 1988-06-23 |
EP0273277B1 (en) | 1992-06-24 |
JPH07116041B2 (ja) | 1995-12-13 |
EP0273277A2 (en) | 1988-07-06 |
NZ222935A (en) | 1990-09-26 |
US4978655A (en) | 1990-12-18 |
IE60866B1 (en) | 1994-08-24 |
EG19157A (en) | 1994-09-29 |
HK55896A (en) | 1996-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2038650T3 (es) | Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus. | |
ES554967A0 (es) | Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido. | |
FI873363A0 (fi) | Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet. | |
PT88930A (pt) | Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem | |
ES2052533T3 (es) | Composicion farmaceutica que comprende 2',3'-didesoxicitidin-2'-eno (2',3'-dideshidrocitidina) para tratar pacientes infectados con retrovirus. | |
BR8806062A (pt) | Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis | |
PT90816A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo analogos de 2',5'-oligoadenilato | |
DK178188A (da) | Antivirusmiddel | |
DK311284D0 (da) | 3-(4'-aminobutylamino)-propylamino-bleomycin-derivater, deres fremstilling og deres anvendelse som laegemidler | |
ATE75613T1 (de) | 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 273277 Country of ref document: ES |
|
SPCF | Request for supplementary protection certificate filed |
Free format text: ESTAVUDINA/ZERIT Spc suppl protection certif: C9800020 Filing date: 19980702 |
|
SPCG | Supplementary protection certificate granted |
Free format text: ESTAVUDINA/ZERIT Spc suppl protection certif: C9800020 Filing date: 19980702 Expiry date: 20110508 |